PT1276486E - Reparação de articulação utilizando células estaminais do mesênquima - Google Patents
Reparação de articulação utilizando células estaminais do mesênquima Download PDFInfo
- Publication number
- PT1276486E PT1276486E PT01930730T PT01930730T PT1276486E PT 1276486 E PT1276486 E PT 1276486E PT 01930730 T PT01930730 T PT 01930730T PT 01930730 T PT01930730 T PT 01930730T PT 1276486 E PT1276486 E PT 1276486E
- Authority
- PT
- Portugal
- Prior art keywords
- joint
- cells
- mesenchymal stem
- stem cells
- tissue
- Prior art date
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 62
- 230000008439 repair process Effects 0.000 title claims description 25
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000008929 regeneration Effects 0.000 claims abstract description 6
- 238000011069 regeneration method Methods 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 75
- 210000001519 tissue Anatomy 0.000 claims description 54
- 210000000845 cartilage Anatomy 0.000 claims description 30
- 208000008558 Osteophyte Diseases 0.000 claims description 28
- 230000003902 lesion Effects 0.000 claims description 23
- 230000006378 damage Effects 0.000 claims description 21
- 230000015572 biosynthetic process Effects 0.000 claims description 20
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 16
- 229920002674 hyaluronan Polymers 0.000 claims description 14
- 229940099552 hyaluronan Drugs 0.000 claims description 14
- 230000000735 allogeneic effect Effects 0.000 claims description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 210000005065 subchondral bone plate Anatomy 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 210000000629 knee joint Anatomy 0.000 claims description 6
- 239000003937 drug carrier Substances 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 4
- 208000034189 Sclerosis Diseases 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 210000001738 temporomandibular joint Anatomy 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 241000366596 Osiris Species 0.000 claims 2
- 230000003011 chondroprotective effect Effects 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 241000283707 Capra Species 0.000 description 72
- 239000003981 vehicle Substances 0.000 description 44
- 210000001503 joint Anatomy 0.000 description 41
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 30
- 241001465754 Metazoa Species 0.000 description 26
- 238000002347 injection Methods 0.000 description 24
- 239000007924 injection Substances 0.000 description 24
- 210000003127 knee Anatomy 0.000 description 22
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 20
- 201000008482 osteoarthritis Diseases 0.000 description 20
- 238000002271 resection Methods 0.000 description 17
- 238000001356 surgical procedure Methods 0.000 description 13
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 10
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 10
- 230000003349 osteoarthritic effect Effects 0.000 description 10
- 239000005090 green fluorescent protein Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 210000001179 synovial fluid Anatomy 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 230000005499 meniscus Effects 0.000 description 8
- 210000004353 tibial menisci Anatomy 0.000 description 8
- 239000006285 cell suspension Substances 0.000 description 7
- 230000026683 transduction Effects 0.000 description 7
- 238000010361 transduction Methods 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 230000003628 erosive effect Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 210000001188 articular cartilage Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 201000010934 exostosis Diseases 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 230000006641 stabilisation Effects 0.000 description 5
- 238000011105 stabilization Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010060820 Joint injury Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 206010061592 cardiac fibrillation Diseases 0.000 description 4
- 230000002600 fibrillogenic effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 210000003041 ligament Anatomy 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 206010006500 Brucellosis Diseases 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010037688 Q fever Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 210000001612 chondrocyte Anatomy 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 206010014599 encephalitis Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 102000046949 human MSC Human genes 0.000 description 3
- 210000000281 joint capsule Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 210000000426 patellar ligament Anatomy 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000003356 suture material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- 206010023215 Joint effusion Diseases 0.000 description 2
- 208000016593 Knee injury Diseases 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009583 bone marrow aspiration Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 208000015100 cartilage disease Diseases 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 201000005043 chondromalacia Diseases 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 210000004394 hip joint Anatomy 0.000 description 2
- 210000004276 hyalin Anatomy 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- MFRCZYUUKMFJQJ-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1COC(=O)CO1 MFRCZYUUKMFJQJ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 1
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000242764 Aequorea victoria Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000486679 Antitype Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003267 Arthritis reactive Diseases 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 206010061762 Chondropathy Diseases 0.000 description 1
- 208000016216 Choristoma Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 229920004937 Dexon® Polymers 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 241000282620 Hylobates sp. Species 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 208000003456 Juvenile Arthritis Diseases 0.000 description 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 241000790101 Myriopus Species 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- GMTYREVWZXJPLF-AFHUBHILSA-N butorphanol D-tartrate Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O.N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 GMTYREVWZXJPLF-AFHUBHILSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000010231 histologic analysis Methods 0.000 description 1
- 210000003035 hyaline cartilage Anatomy 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000002650 immunosuppressive therapy Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 210000002967 posterior cruciate ligament Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 208000002574 reactive arthritis Diseases 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000002660 stem cell treatment Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000000457 tarsus Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 210000003857 wrist joint Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3872—Meniscus for implantation between the natural bone surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19954900P | 2000-04-25 | 2000-04-25 | |
| US23610600P | 2000-09-28 | 2000-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1276486E true PT1276486E (pt) | 2011-02-07 |
Family
ID=26894885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01930730T PT1276486E (pt) | 2000-04-25 | 2001-04-24 | Reparação de articulação utilizando células estaminais do mesênquima |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US20020005205A1 (OSRAM) |
| EP (1) | EP1276486B2 (OSRAM) |
| JP (4) | JP5090604B2 (OSRAM) |
| AT (1) | ATE489101T1 (OSRAM) |
| AU (2) | AU2001257236B2 (OSRAM) |
| CA (1) | CA2405345C (OSRAM) |
| DE (1) | DE60143517D1 (OSRAM) |
| ES (1) | ES2353061T5 (OSRAM) |
| PT (1) | PT1276486E (OSRAM) |
| WO (1) | WO2001080865A2 (OSRAM) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60143517D1 (de) * | 2000-04-25 | 2011-01-05 | Osiris Therapeutics Inc | Wiederherstellung der gelenken mit mesenchymalen stammzellen |
| DE10139783C1 (de) * | 2001-08-14 | 2003-04-17 | Transtissue Technologies Gmbh | Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung |
| CA2468335C (en) * | 2001-12-07 | 2014-07-08 | Geron Corporation | Chondrocyte precursors derived from human embryonic stem cells |
| AR047712A1 (es) * | 2002-09-07 | 2006-02-15 | Royal Veterinary College | Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas |
| SG146691A1 (en) | 2003-10-08 | 2008-10-30 | Vet Stem Inc | Methods of preparing and using stem cell compositions and kits comprising the same |
| US8012693B2 (en) * | 2003-12-16 | 2011-09-06 | 3M Innovative Properties Company | Analysis of chemically crosslinked cellular samples |
| EP2298863B1 (en) | 2004-03-22 | 2015-07-22 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| AU2012205269B2 (en) * | 2004-03-22 | 2015-08-27 | Mesoblast International Sarl | Mesenchymal stem cells and uses therefor |
| TR201901268T4 (tr) * | 2004-03-22 | 2019-02-21 | Mesoblast Int Sarl | Mezenkimal kök hücreleri ve bunların kullanımları. |
| AU2015252160A1 (en) * | 2004-03-22 | 2015-11-26 | Mesoblast International Sarl | Mesenchymal stem cells and uses therefor |
| US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
| JP2008547005A (ja) * | 2005-06-16 | 2008-12-25 | スリーエム イノベイティブ プロパティズ カンパニー | マススペクトルを用いた化学的に架橋された細胞サンプルの分類方法 |
| EP2267030A1 (en) | 2005-08-25 | 2010-12-29 | Repair Technologies, Inc. | Devices, compositions and methods for the protection and repair of cells and tissues |
| GB0600972D0 (en) * | 2006-01-18 | 2006-03-01 | Univ Leeds | Enrichment of cells |
| NZ571127A (en) | 2006-03-07 | 2012-01-12 | Geeta Shroff | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
| US20080260703A1 (en) * | 2007-04-23 | 2008-10-23 | Medistem Labortories | Treatment of Insulin Resistance and Diabetes |
| US9095562B2 (en) | 2007-07-05 | 2015-08-04 | Regenerative Sciences, Inc. | Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
| TR201821239T4 (tr) * | 2007-08-06 | 2019-01-21 | Mesoblast Inc | Bağ dokusu hastalıklarının tedavisinde kullanım için stro-1 parlak hücreler. |
| CN103169731A (zh) * | 2007-08-06 | 2013-06-26 | 成血管细胞系统公司 | 用于体内生成、修复和/或维护结缔组织的方法 |
| AU2013203054B2 (en) * | 2007-08-06 | 2017-05-18 | Mesoblast, Inc. | Methods of generating, repairing and/or maintaining connective tissue in vivo |
| CN101945994A (zh) | 2007-12-19 | 2011-01-12 | 再生科学有限责任公司 | 促进干细胞移植和植入的组合物和方法 |
| CA2713878C (en) * | 2008-02-15 | 2017-01-31 | Bone Therapeutics | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases |
| PL2252290T3 (pl) | 2008-02-15 | 2018-06-29 | Bone Therapeutics S.A. | Kompozycja farmaceutyczna do zastosowania w leczeniu i/lub zapobieganiu chorobom kostno-stawowym |
| EP2090308A1 (en) * | 2008-02-15 | 2009-08-19 | Bone Therapeutics | Pharmaceutical composition for the treatment or prevention of osteoarticular diseases |
| WO2009114785A2 (en) | 2008-03-14 | 2009-09-17 | Regenerative Sciences, Inc. | Compositions and methods for cartilage repair |
| KR20190025067A (ko) | 2008-06-25 | 2019-03-08 | 메소블라스트, 아이엔씨. | 추간판의 치료 및/또는 재구성 |
| US8343480B2 (en) * | 2008-11-14 | 2013-01-01 | Howmedica Osteonics Corp. | Administration of stem or progenitor cells to a joint to enhance recovery from joint surgery |
| US9192695B2 (en) | 2008-11-20 | 2015-11-24 | Allosource | Allografts combined with tissue derived stem cells for bone healing |
| JP2012510874A (ja) | 2008-12-05 | 2012-05-17 | リジェネレイティブ サイエンシーズ， エルエルシー | 無血管組織の修復を促進するための方法及び組成物 |
| US9277999B2 (en) | 2009-02-27 | 2016-03-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Joint bioscaffolds |
| IT1394570B1 (it) | 2009-07-02 | 2012-07-05 | Fidia Farmaceutici | Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni. |
| AU2010306833A1 (en) * | 2009-10-13 | 2012-05-10 | Allocure Inc. | Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same |
| US9113950B2 (en) | 2009-11-04 | 2015-08-25 | Regenerative Sciences, Llc | Therapeutic delivery device |
| BR112013004917A2 (pt) * | 2010-08-31 | 2016-09-20 | Cook General Biotechnology Llc | terapias de células tronco alogênicas sistêmicas para tratamento de doenças em animais. |
| EP4663241A2 (en) | 2010-10-08 | 2025-12-17 | Mesoblast International Sàrl | Enhanced msc preparations |
| US8709401B2 (en) | 2011-02-25 | 2014-04-29 | Howmedica Osteonics Corp. | Primed stem cells and uses thereof to treat inflammatory conditions in joints |
| US20130071360A1 (en) | 2011-06-29 | 2013-03-21 | Biorestorative Therapies, Inc. | Brown Fat Cell Compositions and Methods |
| GB201202319D0 (en) | 2012-02-10 | 2012-03-28 | Orbsen Therapeutics Ltd | Stromal stem cells |
| US9457051B2 (en) * | 2013-01-22 | 2016-10-04 | Animal Cell Therapies, Inc. | Use of stem cells or progenitor cells to treat, delay, prevent, or repair tearing of cruciate ligaments |
| JP6581908B2 (ja) | 2013-02-12 | 2019-09-25 | レプリセル ライフ サイエンシーズ インコーポレイテッド | 腱の治療及び修復用組成物及び方法 |
| CA2894750C (en) | 2013-02-22 | 2021-12-14 | Allosource | Cartilage mosaic compositions and methods |
| WO2014151939A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Perforated osteochondral allograft compositions |
| EP2970882B1 (en) | 2013-03-15 | 2018-11-28 | AlloSource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
| US20150010606A1 (en) * | 2013-07-08 | 2015-01-08 | Arthrex, Inc. | Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase |
| US9597099B2 (en) * | 2013-07-29 | 2017-03-21 | Covidien Lp | Energy-based treatment methods for refractory gout |
| CN105392489B (zh) | 2013-08-01 | 2019-11-22 | 智再如股份有限公司 | 软骨损伤治疗剂及其制造方法 |
| CN106132443A (zh) | 2014-01-28 | 2016-11-16 | 麦迪韦逊技术股份有限公司 | 靶向治疗 |
| WO2015123477A1 (en) * | 2014-02-12 | 2015-08-20 | Replicel Life Sciences Inc. | Compositions and methods for treating bone, joints and cartilage |
| US20170044497A1 (en) | 2014-02-12 | 2017-02-16 | National University Of Ireland, Galway | Selection and use of stem cells |
| RU2559089C1 (ru) * | 2014-04-22 | 2015-08-10 | Государственное автономное учреждение здравоохранения "Республиканская клиническая больница Министерства здравоохранения Республики Татарстан" | Способ восстановления дефектов гиалинового хряща суставных поверхностей суставов конечностей |
| WO2016015007A1 (en) | 2014-07-25 | 2016-01-28 | Recellerate, Inc. | Methods of treating exercise-induced pulmonary hemorrhage |
| TWI566774B (zh) * | 2014-10-06 | 2017-01-21 | 佛教慈濟醫療財團法人花蓮慈濟醫院 | 治療關節疾病的組成物及其方法 |
| RU2644650C2 (ru) | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
| WO2017019832A1 (en) | 2015-07-29 | 2017-02-02 | Medivation Technologies, Inc. | Methods and compositions using repair cells and cationic dyes |
| KR101720329B1 (ko) | 2015-12-11 | 2017-03-28 | 주식회사 에이티앤씨 | 무선통신 단말기용 nfc 및 mst 공용 안테나 장치 |
| RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
| CN106075585B (zh) * | 2016-07-08 | 2019-06-21 | 福建师范大学 | 一种基于人工肌腱支架材料的组织工程化人工肌腱移植物的制备方法 |
| JP7516045B2 (ja) * | 2016-10-07 | 2024-07-16 | サイトリ・セラピューティクス株式会社 | 筋骨格疾患のための再生・細胞療法 |
| US9980984B2 (en) | 2016-10-13 | 2018-05-29 | Kenneth Allen Pettine | Treatment of inflammation of osteoarthritic knees with mesenchymal stem cells |
| WO2018092769A1 (ja) | 2016-11-15 | 2018-05-24 | 株式会社カネカ | 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
| WO2018138322A1 (en) * | 2017-01-27 | 2018-08-02 | Xintela Ab | Prevention and treatment of bone and cartilage damage or disease |
| WO2019102268A1 (en) | 2017-11-22 | 2019-05-31 | Mesoblast International Sarl | Cellular compositions and methods of treatment i |
| JP7454379B2 (ja) | 2017-12-28 | 2024-03-22 | 株式会社カネカ | 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
| US20210047621A1 (en) | 2018-03-12 | 2021-02-18 | Universidade Do Porto | Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells |
| JP7530893B2 (ja) | 2019-06-14 | 2024-08-08 | 株式会社カネカ | 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法 |
| US11583402B2 (en) | 2019-07-16 | 2023-02-21 | William Baumgartl | Method for treating joint pain |
| US20220348880A1 (en) * | 2019-08-30 | 2022-11-03 | The Texas A&M University System | Xenogen-Free Mesenchymal Stem Cell Compositions and Methods of Use |
| US20220290105A1 (en) * | 2019-11-26 | 2022-09-15 | Cells For Cells S.A. | Mesenchymal stem cells with enhanced therapeutic properties |
| AU2021267900A1 (en) | 2020-05-08 | 2023-01-19 | Gallant Pet Inc. | Uterine-derived regenerative cell compositions and uses thereof |
| US12278085B2 (en) | 2022-04-06 | 2025-04-15 | Applied Materials Israel Ltd. | Hybrid scanning electron microscopy and acousto-optic based metrology |
| WO2025076042A1 (en) * | 2023-10-02 | 2025-04-10 | MAM Holdings of West Florida, L.L.C. | Mesenchymal stem cell-mediated treatments for the prevention and targeted treatment of injured tissues and promotion of tissue repair, healing, and regeneration |
| CN120866212A (zh) * | 2025-09-28 | 2025-10-31 | 山东省泉溪生物技术有限公司 | 一种用于膝关节炎治疗的羊膜间充质干细胞及其制备方法与应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL68218A (en) * | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
| US5053050A (en) * | 1988-04-29 | 1991-10-01 | Samuel Itay | Compositions for repair of cartilage and bone |
| US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
| FR2667788B1 (fr) * | 1990-10-12 | 1994-12-02 | Oreal | Utilisation d'hydroxyalkylamino-9,10-anthraquinones pour la teinture de fibres keratiniques humaines, composition cosmetique les contenant en association avec des colorants azouiques et nitres. |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
| US5326357A (en) * | 1992-03-18 | 1994-07-05 | Mount Sinai Hospital Corporation | Reconstituted cartridge tissue |
| US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
| US5716616A (en) * | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
| ATE288480T1 (de) * | 1995-11-16 | 2005-02-15 | Univ Case Western Reserve | Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen |
| US6482231B1 (en) * | 1995-11-20 | 2002-11-19 | Giovanni Abatangelo | Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative |
| PT2111876E (pt) * | 1995-12-18 | 2011-12-23 | Angiodevice Internat Gmbh | Composições de polímero reticulado e seus métodos de utilização |
| US6200606B1 (en) * | 1996-01-16 | 2001-03-13 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| US5842477A (en) * | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
| CA2288690A1 (en) * | 1997-05-13 | 1998-11-19 | Osiris Therapeutics, Inc. | Osteoarthritis cartilage regeneration using human mesenchymal stem cells |
| CA2212300A1 (en) * | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| US6082364A (en) * | 1997-12-15 | 2000-07-04 | Musculoskeletal Development Enterprises, Llc | Pluripotential bone marrow cell line and methods of using the same |
| JP4441115B2 (ja) * | 1998-03-13 | 2010-03-31 | オシリス セラピューティクス，インコーポレイテッド | ヒト非自己間葉幹細胞を使用する方法と利用 |
| IT1299488B1 (it) * | 1998-06-01 | 2000-03-16 | Afatec S R L | Tubo corrugato bimetallico e procedimento per la sua realizzazione |
| JP2002536386A (ja) * | 1999-02-12 | 2002-10-29 | コラジェネシス インク． | 細胞または治療薬の送達のためのコラーゲンベースの注射システム |
| US6716616B1 (en) * | 1999-09-28 | 2004-04-06 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| DE60143517D1 (de) * | 2000-04-25 | 2011-01-05 | Osiris Therapeutics Inc | Wiederherstellung der gelenken mit mesenchymalen stammzellen |
-
2001
- 2001-04-24 DE DE60143517T patent/DE60143517D1/de not_active Expired - Lifetime
- 2001-04-24 JP JP2001577964A patent/JP5090604B2/ja not_active Expired - Lifetime
- 2001-04-24 AT AT01930730T patent/ATE489101T1/de not_active IP Right Cessation
- 2001-04-24 WO PCT/US2001/013267 patent/WO2001080865A2/en not_active Ceased
- 2001-04-24 AU AU2001257236A patent/AU2001257236B2/en not_active Expired
- 2001-04-24 US US09/841,413 patent/US20020005205A1/en not_active Abandoned
- 2001-04-24 ES ES01930730.5T patent/ES2353061T5/es not_active Expired - Lifetime
- 2001-04-24 CA CA2405345A patent/CA2405345C/en not_active Expired - Lifetime
- 2001-04-24 PT PT01930730T patent/PT1276486E/pt unknown
- 2001-04-24 AU AU5723601A patent/AU5723601A/xx active Pending
- 2001-04-24 EP EP01930730.5A patent/EP1276486B2/en not_active Expired - Lifetime
-
2008
- 2008-06-03 US US12/132,290 patent/US20090041730A1/en not_active Abandoned
-
2012
- 2012-02-22 US US13/402,444 patent/US20120148548A1/en not_active Abandoned
- 2012-06-22 JP JP2012141003A patent/JP5792686B2/ja not_active Expired - Lifetime
-
2013
- 2013-01-16 US US13/743,004 patent/US9050178B2/en not_active Expired - Fee Related
-
2015
- 2015-02-25 JP JP2015035361A patent/JP2015128633A/ja active Pending
- 2015-04-16 US US14/687,963 patent/US9814580B2/en not_active Expired - Fee Related
-
2016
- 2016-07-12 JP JP2016137461A patent/JP6382262B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20130131804A1 (en) | 2013-05-23 |
| ES2353061T5 (es) | 2014-04-07 |
| EP1276486B2 (en) | 2014-03-05 |
| JP2012210437A (ja) | 2012-11-01 |
| JP5090604B2 (ja) | 2012-12-05 |
| EP1276486B1 (en) | 2010-11-24 |
| US20120148548A1 (en) | 2012-06-14 |
| US20020005205A1 (en) | 2002-01-17 |
| JP2015128633A (ja) | 2015-07-16 |
| CA2405345A1 (en) | 2001-11-01 |
| JP2016216487A (ja) | 2016-12-22 |
| ATE489101T1 (de) | 2010-12-15 |
| US20150216904A1 (en) | 2015-08-06 |
| WO2001080865A3 (en) | 2002-04-11 |
| EP1276486B8 (en) | 2011-01-19 |
| CA2405345C (en) | 2012-09-18 |
| AU5723601A (en) | 2001-11-07 |
| US9814580B2 (en) | 2017-11-14 |
| AU2001257236B2 (en) | 2006-03-09 |
| JP5792686B2 (ja) | 2015-10-14 |
| ES2353061T3 (es) | 2011-02-25 |
| DE60143517D1 (de) | 2011-01-05 |
| WO2001080865A2 (en) | 2001-11-01 |
| US9050178B2 (en) | 2015-06-09 |
| EP1276486A2 (en) | 2003-01-22 |
| WO2001080865A9 (en) | 2002-12-27 |
| JP6382262B2 (ja) | 2018-08-29 |
| US20090041730A1 (en) | 2009-02-12 |
| JP2004507454A (ja) | 2004-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9814580B2 (en) | Joint repair using mesenchymal stem cells | |
| AU2001257236A1 (en) | Joint repair using mesenchymal stem cells | |
| sadat Toghraie et al. | Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits | |
| Silva et al. | Intra-articular injections of autologous platelet concentrates in dogs with surgical reparation of cranial cruciate ligament rupture | |
| Capeci et al. | Osteochondral allografts: applications in treating articular cartilage defects in the knee | |
| Ude et al. | Long-term evaluation of osteoarthritis sheep knee, treated with TGF-β3 and BMP-6 induced multipotent stem cells | |
| BR112016018704B1 (pt) | processo para produção de um material de cartilagem transplantável para engenharia de tecido | |
| Rodríguez-Merchán | Intra-articular injections of mesenchymal stem cells for knee osteoarthritis | |
| Blanke et al. | Autologous platelet‐rich plasma and fibrin‐augmented minced cartilage implantation in chondral lesions of the knee leads to good clinical and radiological outcomes after more than 12 months: A retrospective cohort study of 71 patients | |
| AU2006200478B2 (en) | Joint repair using mesenchymal stem cells | |
| Zhou et al. | A Macaca fascicularis knee osteoarthritis model developed by modified Hulth combined with joint scratches | |
| Hashimoto et al. | ACL reconstruction using bone‐tendon‐bone graft engineered from the semitendinosus tendon by injection of recombinant BMP‐2 in a rabbit model | |
| Wang et al. | Chondral and Osteochondral Lesions | |
| Wongtriratanachai et al. | Autologous chondrocyte implantation for cartilage injury treatment in Chiang Mai University Hospital: a case report | |
| Mosaid | An Introduction to the Articular Cartilage of the Knee | |
| Credille et al. | Chondral and Osteochondral Lesions in the Patellofemoral Joint | |
| CN120392647A (zh) | 一种小细胞外囊泡复合胶原蛋白水凝胶注射液 | |
| Bugbee et al. | Osteochondral allograft reconstruction: Improvements in surgical techniques and allograft processing | |
| Brand Jr et al. | Complications and pitfalls in meniscal transplantation | |
| Delling et al. | CT-1331 Accepted 12/21/2014 for publication in “Cell Transplantation” Longitudinal evaluation of effects of intraarticular mesenchymal stromal cell administration for the treatment of osteoarthritis in an ovine model | |
| Rodeo et al. | The use of allografts in sports medicine | |
| Delling et al. | CT-1330 Accepted 11/20/2014 for publication in “Cell Transplantation” In vivo tracking and fate of intraarticularly injected superparamagnetic iron oxide particle-labeled multipotent stromal cells in an ovine model of osteoarthritis | |
| Bulstra | Histological, pathological and therapeutical aspects of osteoarthritis | |
| Bach | A New Year | |
| Robb et al. | Veterinary Orthopedic Society 39th Annual Conference Abstracts March 3rd-10th, 2012 Crested Butte, Colorado, USA |